
Oncology Today with Dr Neil Love — Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition
Hematologic Oncology Update
00:00
Benetuzumab and Benetoclax: A Comparison
You would expect that quality of life would be better than continuous BTK. But what about comparing it to just a Benetuzumab, Benetoclax in terms of the patient experience? How would you compare it? And again, I don't know to what extent patient reported outcomes have been done for all these studies.
Transcript
Play full episode